Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum concentrations of paliperidone versus risperidone and clinical effects.
Nazirizadeh Y, Vogel F, Bader W, Haen E, Pfuhlmann B, Gründer G, Paulzen M, Schwarz M, Zernig G, Hiemke C. Nazirizadeh Y, et al. Among authors: grunder g. Eur J Clin Pharmacol. 2010 Aug;66(8):797-803. doi: 10.1007/s00228-010-0812-7. Epub 2010 Apr 1. Eur J Clin Pharmacol. 2010. PMID: 20358189
Therapeutic monitoring of new antipsychotic drugs.
Hiemke C, Dragicevic A, Gründer G, Hätter S, Sachse J, Vernaleken I, Müller MJ. Hiemke C, et al. Among authors: grunder g. Ther Drug Monit. 2004 Apr;26(2):156-60. doi: 10.1097/00007691-200404000-00012. Ther Drug Monit. 2004. PMID: 15228157 Review.
Enhancement of atomoxetine serum levels by co-administration of paroxetine.
Paulzen M, Clement HW, Gründer G. Paulzen M, et al. Among authors: grunder g. Int J Neuropsychopharmacol. 2008 Mar;11(2):289-91. doi: 10.1017/S1461145707008115. Epub 2007 Sep 28. Int J Neuropsychopharmacol. 2008. PMID: 18215333 Free article. No abstract available.
Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G. Vernaleken I, et al. Among authors: grunder g. J Clin Psychopharmacol. 2008 Dec;28(6):608-17. doi: 10.1097/JCP.0b013e31818ba2f6. J Clin Psychopharmacol. 2008. PMID: 19011428 Clinical Trial.
254 results